Shiefa Sequeira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shiefa Sequeira has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
A.V. Rao
1 shared publication- Anjali Rao
Department of Biochemistry, Kasturba Medical College and Hospital, Manipal University, Manipal, Karnataka, India
1 shared publication J. Bhupendra
SRL Diagnostics, Fortis Healthcare Enterprise, Clinical Biochemist, 64, Al Razi Unit 1007, Block A, P.O. Box 505143, Dubai Health Care City, United Arab Emirates
1 shared publicationM. Amargandhi
SRL Diagnostics, Fortis Healthcare Enterprise, Clinical Biochemist, 64, Al Razi Unit 1007, Block A, P.O. Box 505143, Dubai Health Care City, United Arab Emirates
1 shared publicationRubina Lone
Department of Laboratory Medicine, Al Jalila hospital, DHCC, Dubai 100858, United Arab Emirates
1 shared publicationS. Moulali
SRL Diagnostics, Fortis Healthcare Enterprise, Clinical Biochemist, 64, Al Razi Unit 1007, Block A, P.O. Box 505143, Dubai Health Care City, United Arab Emirates
1 shared publication
Latest Publications
- Open Access
- 12 May 2025
- Published by Scientific Scholar in The National Medical Journal of India
- Vol. 38 (1) , 35-40
Challenges during implementation of point-of-care testing in a multispecialty children’s hospital
Point-of-care testing (POCT) has been one of the fastest-growing areas of critical care management. It continues to increase in volume and complexity over the past few years and is now moving to the molecular level. POCT is currently defined as a testing process done near or at the site of patient care by non-laboratory clinical staff. Since these tests are done by clinical staff with minimum technical knowledge, many challenges arise due to a lack of understanding of the process of POCT. The key challenges faced during the successful step-by-step implementation and execution of POCT at our multi-specialty hospital for children in the Middle East included POCT instrumentation, training and competency, quality control issues, proper handling of reagents and consumables, importance of critical call notification, patient identification errors, data management, etc. Many clinical decisions are made based on the results of POCT, hence care should be taken during every step of the POCT process. If implemented appropriately, POCT can have a positive impact on operational efficiency and patient care. Healthcare organizations should innovate rapidly to meet the challenges of POCT.
- 12 May 2025
- Published by Scientific Scholar in The National Medical Journal of India
- Vol. 38 (1) , 35-40
Open AccessChallenges during implementation of point-of-care testing in a multispecialty children’s hospital
Point-of-care testing (POCT) has been one of the fastest-growing areas of critical care management. It continues to increase in volume and complexity over the past few years and is now moving to the molecular level. POCT is currently defined as a testing process done near or at the site of patient care by non-laboratory clinical staff. Since these tests are done by clinical staff with minimum technical knowledge, many challenges arise due to a lack of understanding of the process of POCT. The key challenges faced during the successful step-by-step implementation and execution of POCT at our multi-specialty hospital for children in the Middle East included POCT instrumentation, training and competency, quality control issues, proper handling of reagents and consumables, importance of critical call notification, patient identification errors, data management, etc. Many clinical decisions are made based on the results of POCT, hence care should be taken during every step of the POCT process. If implemented appropriately, POCT can have a positive impact on operational efficiency and patient care. Healthcare organizations should innovate rapidly to meet the challenges of POCT.
- 1 January 2013
- Published by Medknow in Hamdan Medical Journal
- Vol. 6 (2) , 209
Prenatal screening for fetal aneuploidies during the first and second trimester of pregnancy
Prenatal screening for fetal aneuploidies during the first and second trimester of pregnancy
- 1 January 2013
- Published by Medknow in Hamdan Medical Journal
- Vol. 6 (2) , 209
Prenatal screening for fetal aneuploidies during the first and second trimester of pregnancy
Prenatal screening for fetal aneuploidies during the first and second trimester of pregnancy
- 12 October 2012
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 28 (1) , 3-12
First Trimester Maternal Serum Screening Using Biochemical Markers PAPP-A and Free β-hCG for Down Syndrome, Patau Syndrome and Edward Syndrome
The first trimester screening programme offers a noninvasive option for the early detection of aneuploidy pregnancies. This screening is done by a combination of two biochemical markers i.e. serum free β-human chorionic gonadotrophin (free β-hCG) and pregnancy associated plasma protein A (PAPP-A), maternal age and fetal nuchal translucency (NT) thickness at 11 + 0–13 + 6 weeks of gestation. A beneficial consequence of screening is the early diagnosis or trisomies 21, 18 and 13. At 11 + 0–13 + 6 weeks, the relative prevalence of trisomies 18 and 13 to trisomy 21 are found to be one to three and one to seven, respectively. All three trisomies are associated with increased maternal age, increased fetal NT and decreased PAPP-A, but in trisomy 21 serum free β-hCG is increased whereas in trisomies 18 and 13 free β-hCG is decreased.
- 12 October 2012
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 28 (1) , 3-12
First Trimester Maternal Serum Screening Using Biochemical Markers PAPP-A and Free β-hCG for Down Syndrome, Patau Syndrome and Edward Syndrome
The first trimester screening programme offers a noninvasive option for the early detection of aneuploidy pregnancies. This screening is done by a combination of two biochemical markers i.e. serum free β-human chorionic gonadotrophin (free β-hCG) and pregnancy associated plasma protein A (PAPP-A), maternal age and fetal nuchal translucency (NT) thickness at 11 + 0–13 + 6 weeks of gestation. A beneficial consequence of screening is the early diagnosis or trisomies 21, 18 and 13. At 11 + 0–13 + 6 weeks, the relative prevalence of trisomies 18 and 13 to trisomy 21 are found to be one to three and one to seven, respectively. All three trisomies are associated with increased maternal age, increased fetal NT and decreased PAPP-A, but in trisomy 21 serum free β-hCG is increased whereas in trisomies 18 and 13 free β-hCG is decreased.
- 1 October 2008
- Published by Georg Thieme Verlag KG in Homeopathy
- Vol. 97 (4) , 185-189
Lipid peroxidation, erythrocyte antioxidants and plasma antioxidants in osteoarthritis before and after homeopathic treatment
This study attempts to evaluate the status of oxidative stress in osteoarthritis (OA), by measuring some parameters of oxidant stress and antioxidant defenses in blood, before and after homeopathy treatment, and to asses the role, if any, of homeopathic treatment in modulating free radical toxicity in OA. Erythrocyte lipid peroxidation (LP), erythrocyte antioxidants viz., glutathione (GSH), glutathione reductase (GR), superoxide dismutase (SOD), catalase (CT) and plasma antioxidants viz., ceruloplasmin, glutathione-S-transferase (GST), vitamin C, total antioxidant activity (AOA) were determined in eighty one patients with OA and fifty three normals. Forty seven patients, who were treated with homeopathic remedies were considered for the follow-up studies. Father Muller Homeopathic Hospital, Mangalore, South Karnataka, India. Erythrocyte LP (0 hour, p<0.001; 2 hours, p<0.01; and susceptibility to LP, p<0.05) and SOD (p<0.05) were significantly higher, whereas plasma vitamin C (p<0.01) and AOA (p<0.001) were significantly lower in OA patients when compared to controls. In follow-up patients the erythrocyte LP (0 hour, p<0.01; 2 hours, p<0.01; and susceptibility to LP, p<0.01) and SOD (p<0.01) were significantly lower when compared to their pretreatment values. Plasma vitamin C attained a normal range. The AOA activity after treatment was not significantly different from that observed before treatment. Oxidative stress increased in OA as indicated by increased LP, SOD, decreased vitamin C and AOA. On homeopathic treatment the LP has decreased in the erythrocytes which shows and reduced oxidative stress. This is further evidenced by returning of plasma vitamin C and erythrocyte SOD to the normal levels, but oxidant stress has not been completely overcome as plasma AOA remained low after treatment.
- 1 October 2008
- Published by Georg Thieme Verlag KG in Homeopathy
- Vol. 97 (4) , 185-189
Lipid peroxidation, erythrocyte antioxidants and plasma antioxidants in osteoarthritis before and after homeopathic treatment
This study attempts to evaluate the status of oxidative stress in osteoarthritis (OA), by measuring some parameters of oxidant stress and antioxidant defenses in blood, before and after homeopathy treatment, and to asses the role, if any, of homeopathic treatment in modulating free radical toxicity in OA. Erythrocyte lipid peroxidation (LP), erythrocyte antioxidants viz., glutathione (GSH), glutathione reductase (GR), superoxide dismutase (SOD), catalase (CT) and plasma antioxidants viz., ceruloplasmin, glutathione-S-transferase (GST), vitamin C, total antioxidant activity (AOA) were determined in eighty one patients with OA and fifty three normals. Forty seven patients, who were treated with homeopathic remedies were considered for the follow-up studies. Father Muller Homeopathic Hospital, Mangalore, South Karnataka, India. Erythrocyte LP (0 hour, p<0.001; 2 hours, p<0.01; and susceptibility to LP, p<0.05) and SOD (p<0.05) were significantly higher, whereas plasma vitamin C (p<0.01) and AOA (p<0.001) were significantly lower in OA patients when compared to controls. In follow-up patients the erythrocyte LP (0 hour, p<0.01; 2 hours, p<0.01; and susceptibility to LP, p<0.01) and SOD (p<0.01) were significantly lower when compared to their pretreatment values. Plasma vitamin C attained a normal range. The AOA activity after treatment was not significantly different from that observed before treatment. Oxidative stress increased in OA as indicated by increased LP, SOD, decreased vitamin C and AOA. On homeopathic treatment the LP has decreased in the erythrocytes which shows and reduced oxidative stress. This is further evidenced by returning of plasma vitamin C and erythrocyte SOD to the normal levels, but oxidant stress has not been completely overcome as plasma AOA remained low after treatment.